{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:30:20Z","timestamp":1761183020452,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jiac.2017.07.008","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T15:00:21Z","timestamp":1501772421000},"page":"683-686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adverse events of prophylactic anti-influenza agents in medical staffs"],"prefix":"10.1016","volume":"23","author":[{"given":"Hideo","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao","family":"Hagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Kurumiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Furui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2014","author":"World Health Organization","series-title":"Influenza (seasonal). Fact sheet No 211","key":"10.1016\/j.jiac.2017.07.008_bib1"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.jiac.2017.07.008_bib2","first-page":"ii5","article-title":"Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations","volume":"65","author":"Davies","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"year":"2009","author":"World Health Organization","series-title":"Recommended use of antivirals: pandemic (H1N1) 2009 briefing note 8 [internet]","key":"10.1016\/j.jiac.2017.07.008_bib3"},{"year":"2008","author":"Roche Tamiflu (Oseltamivir Phosphate) Capsules and for Oral Suspension","series-title":"Centres for disease control and prevention","key":"10.1016\/j.jiac.2017.07.008_bib4"},{"year":"2009","author":"Centres for Disease Control and Prevention","series-title":"Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009\u20132010 season [internet]","key":"10.1016\/j.jiac.2017.07.008_bib5"},{"key":"10.1016\/j.jiac.2017.07.008_bib6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/INF.0b013e318260265a","article-title":"Postexposure prophylaxis for influenza in pediatric wards oseltamivir or zanamivir after rapid antigen detection","volume":"31","author":"Shinjoh","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2017.07.008_bib7","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMc0910060","article-title":"Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis","volume":"361","author":"Baz","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2017.07.008_bib8","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJM198912213212502","article-title":"Emergence and apparent transmission of rimantadine-resistant influenza A virus in families","volume":"321","author":"Hayden","year":"1989","journal-title":"N\u00a0Engl J Med"},{"unstructured":"Tamiflu oseltamivir phosphate for oral capsule [prescribing information]. Roche.","key":"10.1016\/j.jiac.2017.07.008_bib9"},{"key":"10.1016\/j.jiac.2017.07.008_bib10","first-page":"1639","article-title":"Use of oseltamivir for prevention of novel influenza A (H1N1) infection in healthcare personnel: treatment compliance and incidence of adverse events","volume":"45","author":"Nakasako","year":"2009","journal-title":"J\u00a0Jpn Soc Hosp Pharm"},{"key":"10.1016\/j.jiac.2017.07.008_bib11","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.11150\/kansenshogakuzasshi1970.74.1062","article-title":"Efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir for prophylaxis against influenza-placebo-controlled double-blind multicenter phase \u2162 trial","volume":"74","author":"Kashiwagi","year":"2000","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.jiac.2017.07.008_bib12","first-page":"887","article-title":"Investigation of the reconsultation rate and pharmacoeconomic evaluation of period of influenza treatment by oseltamivir","volume":"123","author":"Yamaura","year":"2003","journal-title":"YakugakuZasshi"},{"key":"10.1016\/j.jiac.2017.07.008_bib13","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US oral neuraminidase study group","volume":"283","author":"Treanor","year":"2000","journal-title":"JAMA"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17301575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17301575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:56:46Z","timestamp":1761159406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X17301575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1341321X17301575"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2017.07.008","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events of prophylactic anti-influenza agents in medical staffs","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2017.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}